| Dexamethasone | Approved Investigational Vet Approved | CCNA2 | 890 |
upregulated | Dexamethasone results in increased expression of CCNA2 mRNA | 4q27 | |
| Dexamethasone | Approved Investigational Vet Approved | CCNB1 | 891 |
upregulated | Dexamethasone results in increased expression of CCNB1 mRNA | 5q13.2 | |
| Dexamethasone | Approved Investigational Vet Approved | CCND1 | 595 |
downregulated | Dexamethasone results in decreased expression of CCND1 mRNA | 11q13.3 | |
| Dexamethasone | Approved Investigational Vet Approved | CCND2 | 894 |
downregulated | Dexamethasone results in decreased expression of CCND2 mRNA | 12p13.32 | |
| Dexamethasone | Approved Investigational Vet Approved | CCR4 | 1233 |
upregulated | Dexamethasone results in increased expression of CCR4 mRNA | 3p22.3 | |
| Dexamethasone | Approved Investigational Vet Approved | CD302 | 9936 |
upregulated | Dexamethasone results in increased expression of CD302 mRNA | 2q24.2 | |
| Dexamethasone | Approved Investigational Vet Approved | CD36 | 948 |
upregulated | Dexamethasone results in increased expression of CD36 mRNA | 7q21.11 | |
| Dexamethasone | Approved Investigational Vet Approved | CD53 | 963 |
upregulated | Dexamethasone results in increased expression of CD53 mRNA | 1p13.3 | |
| Dexamethasone | Approved Investigational Vet Approved | CD69 | 969 |
upregulated | Dexamethasone results in increased expression of CD69 mRNA | 12p13.31 | |
| Dexamethasone | Approved Investigational Vet Approved | CDC42EP2 | 10435 |
upregulated | Dexamethasone results in increased expression of CDC42EP2 mRNA | 11q13.1 | |
| Dexamethasone | Approved Investigational Vet Approved | CDH2 | 1000 |
downregulated | Dexamethasone results in decreased expression of CDH2 mRNA | 18q12.1 | |
| Dexamethasone | Approved Investigational Vet Approved | CDK1 | 983 |
upregulated | Dexamethasone results in increased expression of CDK1 mRNA | 10q21.2 | |
| Dexamethasone | Approved Investigational Vet Approved | CDK2 | 1017 |
downregulated | Dexamethasone results in decreased expression of CDK2 mRNA | 12q13.2 | |
| Dexamethasone | Approved Investigational Vet Approved | CDK2 | 1017 |
upregulated | Dexamethasone results in increased expression of CDK2 mRNA | 12q13.2 | |
| Dexamethasone | Approved Investigational Vet Approved | CDKN1A | 1026 |
upregulated | Dexamethasone results in increased expression of CDKN1A mRNA | 6p21.2 | |
| Dexamethasone | Approved Investigational Vet Approved | CDKN1B | 1027 |
upregulated | Dexamethasone results in increased expression of CDKN1B mRNA | 12p13.1 | |
| Dexamethasone | Approved Investigational Vet Approved | CDKN1C | 1028 |
upregulated | Dexamethasone results in increased expression of CDKN1C mRNA | 11p15.4 | |
| Dexamethasone | Approved Investigational Vet Approved | CDKN2C | 1031 |
upregulated | Dexamethasone results in increased expression of CDKN2C mRNA | 1p32.3 | |
| Dexamethasone | Approved Investigational Vet Approved | CDO1 | 1036 |
upregulated | Dexamethasone results in increased expression of CDO1 mRNA | 5q22.3 | |
| Dexamethasone | Approved Investigational Vet Approved | CEBPA | 1050 |
upregulated | Dexamethasone results in increased expression of CEBPA mRNA | 19q13.11 | |
| Dexamethasone | Approved Investigational Vet Approved | CELF2 | 10659 |
upregulated | Dexamethasone results in increased expression of CELF2 mRNA | 10p14 | |
| Dexamethasone | Approved Investigational Vet Approved | CELSR3 | 1951 |
downregulated | Dexamethasone results in decreased expression of CELSR3 mRNA | 3p21.31 | |
| Dexamethasone | Approved Investigational Vet Approved | CEMIP | 57214 |
downregulated | Dexamethasone results in decreased expression of CEMIP mRNA | 15q25.1 | |
| Dexamethasone | Approved Investigational Vet Approved | CEND1 | 51286 |
upregulated | Dexamethasone results in increased expression of CEND1 mRNA | 11p15.5 | |
| Dexamethasone | Approved Investigational Vet Approved | CES1 | 1066 |
upregulated | Dexamethasone results in increased expression of CES1 mRNA | 16q12.2 | |